This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Jason Damiano
Chief Scientific Officer at Appia Bio


Dr. Jason Damiano is the Chief Scientific Officer of Appia Bio, leading research focused on a pipeline of off-the-shelf engineered CAR-NKT and CAR-gamma delta T cell therapies for oncology and autoimmune disease applications. Prior to joining Appia Bio, Jason led successful innovative drug discovery and biology groups at Unity Biotechnology, Achaogen, Igenica and the Novartis Institutes for BioMedical Research. Jason completed his Ph.D. training in cancer biology & pharmacology at the University of Arizona and trained as a postdoc in apoptosis & inflammation research under John Reed at the Sanford Burnham Prebys Medical Research Institute.

Agenda Sessions

  • Armored HSC-Derived CAR-iNKT: A Differentiated Platform To Target Solid Tumors